Poor nations pitch drug-patent pool

Can poor countries get the meds they need for their people only by circumventing patents? That's the debate this week at a WHO confab aimed at supplying the developing world with the drugs it needs. So far, some non-governmental organizations and poor nations have proposed "patent pools" that would combine intellectual property rights on existing meds and a prize fund to incentivize drug makers to develop remedies for neglected--read less profitable--diseases.

Don't expect Big Pharma to jump on the bandwagon, though. The proposed measures would reward drug makers for their R&D. But under the proposals, generic companies could step in as soon as products are launched, so the upfront rewards probably couldn't compensate for long-term loss of revenue.

Other WHO ideas include more support for compulsory licenses, which force drug makers to grant rights to epidemic-ridden countries that can't otherwise afford the right pharmaceuticals.

- read the report from the Financial Times

Related Articles:
New malaria vaccine offers better protection. Report
Thailand skirts Plavix patent. Report
WHO: Infectious disease a growing threat. Report
EU ratifies compulsory drug licensing. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.